Showing results (331-340 of 374) with videos related to

Sort By:
Pageof 38
Gynecologic Oncology|July 10, 2020
Phase II study of axalimogene filolisbac (ADXS-HPV) for platinum-refractory cervical carcinoma: An NRG oncology/gynecologic oncology group studyWarner K Huh, William E Brady, Paula M Fracasso, et al.
Gynecologic Oncology|January 29, 2002
Conservative management of stage I endometrial carcinoma after surgical stagingJ Michael Straughn, Warner K Huh, F Joseph Kelly, et al.
Journal of Lower Genital Tract Disease|September 28, 2017
ASCCP Colposcopy Standards: How Do We Perform Colposcopy? Implications for Establishing StandardsAlan G Waxman, Christine Conageski, Michelle I Silver, et al.
Gynecologic Oncology|April 26, 2003
Stage IC adenocarcinoma of the endometrium: survival comparisons of surgically staged patients with and without adjuvant radiation therapyJ Michael Straughn, Warner K Huh, James W Orr, et al.
Journal of Lower Genital Tract Disease|January 10, 2015
Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidanceWarner K Huh, Kevin A Ault, David Chelmow, et al.
Gynecologic Oncology|January 13, 2015
Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidanceWarner K Huh, Kevin A Ault, David Chelmow, et al.
Obstetrics and Gynecology|May 2, 2007
Clinical and pathologic correlates in surgical stage II endometrial carcinomaDavid E Cohn, Emily M Woeste, Stacey Cacchio, et al.
Obstetrics and Gynecology|December 2, 2014
Detection of somatic TP53 mutations in tampons of patients with high-grade serous ovarian cancerBritt K Erickson, Isaac Kinde, Zachary C Dobbin, et al.
Gynecologic Oncology|December 1, 2015
A pilot study of pNGVL4a-CRT/E7(detox) for the treatment of patients with HPV16+ cervical intraepithelial neoplasia 2/3 (CIN2/3)Ronald D Alvarez, Warner K Huh, Sejong Bae, et al.
Gynecologic Oncology|March 19, 2018
Correlation between Surgeon's assessment and radiographic evaluation of residual disease in women with advanced stage ovarian cancer reported to have undergone optimal surgical cytoreduction: An NRG Oncology/Gynecologic Oncology Group studyRamez N Eskander, James Kauderer, Krishnansu S Tewari, et al.
Pageof 38